Xiaodong Wang - Nov 30, 2023 Form 4 Insider Report for BeiGene, Ltd. (BGNE)

Role
Director, Chair, Scientific Advisory Brd
Signature
/s/ Qing Nian, Attorney-in-Fact
Stock symbol
BGNE
Transactions as of
Nov 30, 2023
Transactions value $
$0
Form type
4
Date filed
12/4/2023, 05:44 PM
Previous filing
Jun 20, 2023
Next filing
Jun 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BGNE Ordinary Shares Gift $0 -71.9K -1.3% $0.00 5.46M Nov 30, 2023 Direct F1
transaction BGNE Ordinary Shares Other $0 -172K -100% $0.00* 0 Nov 30, 2023 See Footnote F3, F4
holding BGNE Ordinary Shares 1.13M Nov 30, 2023 See Footnote F2
holding BGNE Ordinary Shares 4.06M Nov 30, 2023 See Footnote F5
holding BGNE Ordinary Shares 50 Nov 30, 2023 See Footnote F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Bona fide gift(s) of shares which are exempt from Section 16(b) of the Securities Exchange Act pursuant to Rule 16b-5.
F2 These securities are held by a family trust, the beneficiaries of which are the Reporting Person's family members, for which the Reporting Person disclaims beneficial ownership.
F3 Shares held by adult child that is no longer living in reporting person's household.
F4 These securities were held in a UTMA account for the Reporting Person's child, for which the Reporting Person disclaimed beneficial ownership.
F5 These securities are held by Wang Investment LLC, of which 99% of the limited liability company interest is owned by two grantor retained annuity trusts, of which the Reporting Person's wife is a trustee, for which the Reporting Person disclaims beneficial ownership.
F6 These securities are held by the spouse of the Reporting Person.